Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Flow cytometric immunophenotyping of regulatory T cells in chronic lymphocytic leukemia: comparative assessment of various markers and use of novel antibody panel with CD127 as alternative to transcription factor FoxP3.

Dasgupta A, Mahapatra M, Saxena R.

Leuk Lymphoma. 2013 Apr;54(4):778-89. doi: 10.3109/10428194.2012.730614. Epub 2012 Oct 5.

PMID:
22989355
[PubMed - indexed for MEDLINE]
2.

Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells.

Piper KP, Karanth M, McLarnon A, Kalk E, Khan N, Murray J, Pratt G, Moss PA.

Clin Exp Immunol. 2011 Nov;166(2):154-63. doi: 10.1111/j.1365-2249.2011.04466.x.

PMID:
21985361
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.

Pan XD, Mao YQ, Zhu LJ, Li J, Xie Y, Wang L, Zhang GB.

Chin Med J (Engl). 2012 Jun;125(11):2004-11.

PMID:
22884069
[PubMed - indexed for MEDLINE]
Free Article
4.

CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood.

Klein S, Kretz CC, Krammer PH, Kuhn A.

J Invest Dermatol. 2010 Feb;130(2):492-9. doi: 10.1038/jid.2009.313. Epub 2009 Nov 26.

PMID:
19940860
[PubMed - indexed for MEDLINE]
Free Article
5.

Identification, frequency, activation and function of CD4+ CD25(high)FoxP3+ regulatory T cells in children with juvenile idiopathic arthritis.

Stelmaszczyk-Emmel A, Jackowska T, Rutkowska-Sak L, Marusak-Banacka M, Wąsik M.

Rheumatol Int. 2012 May;32(5):1147-54. doi: 10.1007/s00296-010-1728-3. Epub 2011 Jan 20.

PMID:
21249500
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.

Shen LS, Wang J, Shen DF, Yuan XL, Dong P, Li MX, Xue J, Zhang FM, Ge HL, Xu D.

Clin Immunol. 2009 Apr;131(1):109-18. doi: 10.1016/j.clim.2008.11.010. Epub 2009 Jan 18.

PMID:
19153062
[PubMed - indexed for MEDLINE]
7.

Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia.

Gowda A, Ramanunni A, Cheney C, Rozewski D, Kindsvogel W, Lehman A, Jarjoura D, Caligiuri M, Byrd JC, Muthusamy N.

MAbs. 2010 Jan-Feb;2(1):35-41. Epub 2010 Jan 8.

PMID:
20081380
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Defective circulating CD4CD25+Foxp3+CD127(low) regulatory T-cells in patients with chronic heart failure.

Tang TT, Ding YJ, Liao YH, Yu X, Xiao H, Xie JJ, Yuan J, Zhou ZH, Liao MY, Yao R, Cheng Y, Cheng X.

Cell Physiol Biochem. 2010;25(4-5):451-8. doi: 10.1159/000303050. Epub 2010 Mar 23.

PMID:
20332626
[PubMed - indexed for MEDLINE]
9.

Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.

Sobel ES, Brusko TM, Butfiloski EJ, Hou W, Li S, Cuda CM, Abid AN, Reeves WH, Morel L.

Arthritis Res Ther. 2011 Jun 27;13(3):R106. doi: 10.1186/ar3387.

PMID:
21708033
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?

Yang HX, Zhang W, Zhao LD, Li Y, Zhang FC, Tang FL, He W, Zhang X.

Arthritis Res Ther. 2009;11(5):R153. doi: 10.1186/ar2829. Epub 2009 Oct 12.

PMID:
19821980
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Requirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLR.

Yu Y, Miller J, Leventhal JR, Tambur AR, Chandrasekaran D, Levitsky J, Luo X, Mathew JM.

PLoS One. 2011;6(7):e22450. doi: 10.1371/journal.pone.0022450. Epub 2011 Jul 22.

PMID:
21799858
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects.

Saison J, Demaret J, Venet F, Chidiac C, Malcus C, Poitevin-Later F, Tardy JC, Ferry T, Monneret G.

Cytometry B Clin Cytom. 2013 Jan-Feb;84(1):50-4. doi: 10.1002/cyto.b.21047. Epub 2012 Sep 27.

PMID:
23019018
[PubMed - indexed for MEDLINE]
Free Article
13.

Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.

Beyer M, Classen S, Endl E, Kochanek M, Weihrauch MR, Debey-Pascher S, Knolle PA, Schultze JL.

Clin Dev Immunol. 2011;2011:734036. doi: 10.1155/2011/734036. Epub 2011 Aug 28.

PMID:
21904560
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Regulatory T-cells in B-cell chronic lymphocytic leukemia: their role in disease progression and autoimmune cytopenias.

Lad DP, Varma S, Varma N, Sachdeva MU, Bose P, Malhotra P.

Leuk Lymphoma. 2013 May;54(5):1012-9. doi: 10.3109/10428194.2012.728287. Epub 2012 Oct 16.

PMID:
23009220
[PubMed - indexed for MEDLINE]
15.

Significance of immunoregulatory T cells in different stages of breast cancer patients.

Abo-Elenein A, Elgohary SE, Hashish A, El-Halaby E.

Egypt J Immunol. 2008;15(2):145-52.

PMID:
20306697
[PubMed - indexed for MEDLINE]
16.

Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.

Kakita N, Kanto T, Itose I, Kuroda S, Inoue M, Matsubara T, Higashitani K, Miyazaki M, Sakakibara M, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.

Int J Cancer. 2012 Dec 1;131(11):2573-83. doi: 10.1002/ijc.27535. Epub 2012 Mar 29.

PMID:
22419479
[PubMed - indexed for MEDLINE]
17.

Human CD4+CD25(high)CD127 (low/neg) regulatory T cells.

Su H, Longhi MS, Wang P, Vergani D, Ma Y.

Methods Mol Biol. 2012;806:287-99. doi: 10.1007/978-1-61779-367-7_20.

PMID:
22057460
[PubMed - indexed for MEDLINE]
18.

[Frequency of the CD4+CD25nt/hiCD127lo regulatory T lymphocytes from the peripheral blood in Chinese healthy individuals].

Wang Y, Zhou LM, Gong JL, Zhou MK, Shen FW, Zheng XH, Zhang W, Zhuang MH, Lu W, Zhong P, Pan QC, Kang LY.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Sep;23(9):816-8. Chinese.

PMID:
17825226
[PubMed - indexed for MEDLINE]
19.

[The percentage of regulatory T cells in peripheral blood of chronic lymphocytic leukemia patients and the correlations with clinical prognosis].

Xie P, Pang N, Guo X, Wang L, Zhao F, Wang X, Qu J.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013 Dec;29(12):1307-11. Chinese.

PMID:
24321076
[PubMed - indexed for MEDLINE]
20.

No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.

Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D, Haller M, Rockell J, Gottlieb P, Clare-Salzler M, Atkinson M.

Diabetes. 2007 Mar;56(3):604-12.

PMID:
17327427
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk